SHARE
Anaplastic Thyroid Cancer Drugs - Global Market Outlook (2017-2026)

Anaplastic Thyroid Cancer Drugs - Global Market Outlook (2017-2026)

Published: June 2019 ID: SMRC18317
Published: June 2019 ID: SMRC18317

1 Executive Summary                  
                   
2 Preface                  
 2.1 Abstract                 
 2.2 Stake Holders                 
 2.3 Research Scope                 
 2.4 Research Methodology                 
  2.4.1 Data Mining                
  2.4.2 Data Analysis                
  2.4.3 Data Validation                
  2.4.4 Research Approach                
 2.5 Research Sources                 
  2.5.1 Primary Research Sources                
  2.5.2 Secondary Research Sources                
  2.5.3 Assumptions                
                   
3 Market Trend Analysis                  
 3.1 Introduction                 
 3.2 Drivers                 
 3.3 Restraints                 
 3.4 Opportunities                 
 3.5 Threats                 
 3.6 Product Analysis                 
 3.7 Application Analysis                 
 3.8 Emerging Markets                 
 3.9 Futuristic Market Scenario                 
                   
4 Porters Five Force Analysis                  
 4.1 Bargaining power of suppliers                 
 4.2 Bargaining power of buyers                 
 4.3 Threat of substitutes                 
 4.4 Threat of new entrants                 
 4.5 Competitive rivalry                 
                   
5 Global Anaplastic Thyroid Cancer Drugs Market, By Type                  
 5.1 Introduction                 
 5.2 Crolibulin                 
 5.3 Efatutazone                 
 5.4 GLONC-2                 
 5.5 CLM-94                 
 5.6 Other Types                 
                   
6 Global Anaplastic Thyroid Cancer Drugs Market, By Product                  
 6.1 Introduction                 
 6.2 Sorafenib (phase 2)                 
 6.3 Paclitaxel and Pazopanib HCl (phase 2)                 
 6.4 MLN0128 (phase 2)                 
 6.5 Lapatinib Ditosylate and Dabrafenib (phase 1)                 
 6.6 Everolimus (phase 2)                 
 6.7 CS7017 (phase 1)                 
 6.8 Crolibulin (phase 1)                 
 6.9 Cabozantinib (phase 2)                 
 6.10 CA4P (phase 2)                 
 6.11 Bevacizumab (phase 2)                 
 6.12 Other Products                 
                   
7 Global Anaplastic Thyroid Cancer Drugs Market, By Treatments                  
 7.1 Introduction                 
 7.2 Surgical Treatments                 
 7.3 Radiation Therapy                 
 7.4 Novel Therapy                 
 7.5 Cryosurgery                 
 7.6 Chemotherapy                 
                   
8 Global Anaplastic Thyroid Cancer Drugs Market, By Method                  
 8.1 Introduction                 
 8.2 Oral                  
 8.3 Injection                 
                   
9 Global Anaplastic Thyroid Cancer Drugs Market, By Application                  
 9.1 Introduction                 
 9.2 Clinic                 
 9.3 Hospital                 
 9.4 Other Applications                 
                   
10 Global Anaplastic Thyroid Cancer Drugs Market, By Geography                  
 10.1 Introduction                 
 10.2 North America                 
  10.2.1 US                
  10.2.2 Canada                
  10.2.3 Mexico                
 10.3 Europe                 
  10.3.1 Germany                
  10.3.2 UK                
  10.3.3 Italy                
  10.3.4 France                
  10.3.5 Spain                
  10.3.6 Rest of Europe                
 10.4 Asia Pacific                 
  10.4.1 Japan                
  10.4.2 China                
  10.4.3 India                
  10.4.4 Australia                
  10.4.5 New Zealand                
  10.4.6 South Korea                
  10.4.7 Rest of Asia Pacific                
 10.5 South America                 
  10.5.1 Argentina                
  10.5.2 Brazil                
  10.5.3 Chile                
  10.5.4 Rest of South America                
 10.6 Middle East & Africa                 
  10.6.1 Saudi Arabia                
  10.6.2 UAE                
  10.6.3 Qatar                
  10.6.4 South Africa                
  10.6.5 Rest of Middle East & Africa                
                   
11 Key Developments                  
 11.1 Agreements, Partnerships, Collaborations and Joint Ventures                 
 11.2 Acquisitions & Mergers                 
 11.3 New Product Launch                 
 11.4 Expansions                 
 11.5 Other Key Strategies                 
                   
12 Company Profiling                  
 12.1 Pfizer Inc.                 
 12.2 Daiichi Sankyo Company, Limited                 
 12.3 Trophogen, Inc.                 
 12.4 Plexxikon Inc.                 
 12.5 Novartis AG                 
 12.6 Millennium Pharmaceuticals Inc                 
 12.7 Immune Pharmaceuticals Inc.                 
 12.8 Genelux Corporation


List of Tables                   
1 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Region (2016-2026) (US $MN)                   
2 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Type (2016-2026) (US $MN)                  
3 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Crolibulin (2016-2026) (US $MN)                  
4 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Efatutazone (2016-2026) (US $MN)                  
5 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By GLONC-2 (2016-2026) (US $MN)                  
6 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By CLM-94 (2016-2026) (US $MN)                  
7 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Other Types (2016-2026) (US $MN)                  
8 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Product (2016-2026) (US $MN)                  
9 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Sorafenib (phase 2) (2016-2026) (US $MN)                  
10 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Paclitaxel and Pazopanib HCl (phase 2) (2016-2026) (US $MN)                  
11 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By MLN0128 (phase 2) (2016-2026) (US $MN)                  
12 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Lapatinib Ditosylate and Dabrafenib (phase 1) (2016-2026) (US $MN)                  
13 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Everolimus (phase 2) (2016-2026) (US $MN)                  
14 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By CS7017 (phase 1) (2016-2026) (US $MN)                  
15 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Crolibulin (phase 1) (2016-2026) (US $MN)                  
16 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Cabozantinib (phase 2) (2016-2026) (US $MN)                  
17 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By CA4P (phase 2) (2016-2026) (US $MN)                  
18 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Bevacizumab (phase 2) (2016-2026) (US $MN)                  
19 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Other Products (2016-2026) (US $MN)                  
20 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Treatments (2016-2026) (US $MN)                  
21 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Surgical Treatments (2016-2026) (US $MN)                  
22 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Radiation Therapy (2016-2026) (US $MN)                  
23 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Novel Therapy (2016-2026) (US $MN)                  
24 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Cryosurgery (2016-2026) (US $MN)                  
25 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Chemotherapy (2016-2026) (US $MN)                  
26 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Method (2016-2026) (US $MN)                  
27 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Oral (2016-2026) (US $MN)                  
28 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Injection (2016-2026) (US $MN)                  
29 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Application (2016-2026) (US $MN)                  
30 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Clinic (2016-2026) (US $MN)                  
31 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Hospital (2016-2026) (US $MN)                  
32 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Other Applications (2016-2026) (US $MN)                  
                   
NOTE: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa are represented in the same manner above.         

 

Select License Type

Single User License (PDF)
2 - 5 User License (PDF)
Site License (PDF)
Corporate License (PDF)

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials